Skip to main content
Bulletin of the National Research Centre

Table 1 Chemical structure, experimental and predicted pIC50 of Quinazoline derivatives

From: In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

Back to article page